Serial Changes in the Coagulation System Following Clotting Factor Concentrate Infusion

F. E Preston; D. A Winfield; R. G Malia; E. K Blackburn

doi:10.1055/s-0038-1651406

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1975; 34(02): 475-482
DOI: 10.1055/s-0038-1651406

Original Article

Schattauer GmbH

Serial Changes in the Coagulation System Following Clotting Factor Concentrate Infusion

Authors

F. E Preston

¹University Department of Haematology, The Royal Infirmary, Sheffield S63 DA, England
D. A Winfield

¹University Department of Haematology, The Royal Infirmary, Sheffield S63 DA, England
R. G Malia

¹University Department of Haematology, The Royal Infirmary, Sheffield S63 DA, England
E. K Blackburn

¹University Department of Haematology, The Royal Infirmary, Sheffield S63 DA, England

Abstract

Summary

Various parameters of the coagulation system have been monitored in patients with Christmas disease following the infusion of clotting factor concentrates. Significant reduction of clotting factor VIII and serum antithrombin III were observed in each of the five studies, whilst the plasma fibrinogen level fell in four subjects. The induced abnormalities were shortlived and there were no clinical sequelae. Further studies are required to assess the effects of similar concentrates in patients with liver disease.

Full Text

References

References
1 Bidwell E, and Dike G. W. R. 1966. Therapeutic Materials. In: Biggs R, and Macfarlane R. G. (eds.) Treatment of Haemophilia and other coagulation disorders. Blackwell Scientific Publications; Oxford: 43.
2 Bidwell E, Dike G. W. R, and Ford W. H. 1972. Therapeutic Materials. In: Biggs R. (ed.) Human Blood Coagulation, Haemostasis and Thrombosis. Blackwell Scientific Publications; Oxford: 225.
3 Denson K. W. E, and Biggs R. 1972. Laboratory diagnosis, tests of clotting function and their standardisation. In: Biggs R. (ed.) Human Blood Coagulation, Haemostasis and Thrombosis. Blackwell Scientific Publications; Oxford: 278.
4 Deykin D. 1966; The role of the liver in serum-induced hypercoagulability. Journal of Clinical Investigation 45: 256.
5 Duthie R. B, Matthews J. M, Rizza C. R, and Steel W. M. 1972. The management of musculoskeletal problems in the haemophilias. Blackwell Scientific Publications; Oxford, London, Edinburgh, Melbourne:
6 Ellis B.C, and Stransky A. 1961; A quick and accurate method for the determination of fibrinogen in plasma. Journal of Laboratory and Clinical Medicine 58: 477.
7 Kasper C. K. 1973; Postoperative thromboses in haemophilia B. New England Journal of Medicine 289: 160.
8 Leading Article. 1972; Clotting factor concentrates. British Medical Journal 1: 66.
9 Merksey C, Johnson A. J, Kleiner G. J, and Wohl H. 1967; The defibrination syndrome: Clinical features and laboratory diagnosis. British Journal of Haematology 13: 528.
10 Yin E, Wessler S, and Stoll P. 1971; a Identity of plasma-activated factor X inhibitor with anti-thrombin III and heparin co-factor. Journal of Biological Chemistry 246: 3712.
11 Yin E, Wessler S, and Stoll P. 1971; b Biological properties of the naturally occurring plasma inhibitor to activated factor X. Journal of Biological Chemistry 246: 3703.